terazosin has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
Excerpt | Relevance | Reference |
---|---|---|
"The effects of the alpha-1-adrenergic blocker terazosin on blood pressure and fasting and postprandial glucose and lipid metabolism were assessed in type 2 diabetic patients with hypertension." | 9.09 | Effects of a 3-month treatment with terazosin on fasting and postprandial glucose and lipid metabolism in type 2 diabetic patients with hypertension. ( Ferrara, LA; Imperatore, G; Iovine, C; Pasanisi, F; Vaccaro, O, 1999) |
"The effects of the alpha-1-adrenergic blocker terazosin on blood pressure and fasting and postprandial glucose and lipid metabolism were assessed in type 2 diabetic patients with hypertension." | 5.09 | Effects of a 3-month treatment with terazosin on fasting and postprandial glucose and lipid metabolism in type 2 diabetic patients with hypertension. ( Ferrara, LA; Imperatore, G; Iovine, C; Pasanisi, F; Vaccaro, O, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wu, CS | 1 |
Sung, SF | 1 |
Tong, SH | 1 |
Ong, CT | 1 |
Pasanisi, F | 1 |
Imperatore, G | 1 |
Vaccaro, O | 1 |
Iovine, C | 1 |
Ferrara, LA | 1 |
1 trial available for terazosin and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Effects of a 3-month treatment with terazosin on fasting and postprandial glucose and lipid metabolism in type 2 diabetic patients with hypertension.
Topics: Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Area Under Curve; Blood Glucose; Choleste | 1999 |
1 other study available for terazosin and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Multiple cerebral infarctions related to famotidine-induced eosinophilia.
Topics: Acarbose; Adrenergic alpha-1 Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulc | 2012 |